These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 19655820

  • 21. [Nebivolol treatment in essential arterial hypertension].
    Ghiuru R, Rezuş C, Ambăruş V, Ionescu S, Cosovanu A.
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):756-9. PubMed ID: 12092233
    [Abstract] [Full Text] [Related]

  • 22. [Pharmacological modulation of NO synthesis in patients with arterial hypertension and endothelial dysfunction].
    Buval'tsev VI, Spasskaia MB, Nebieridze DV, Metel'skaia VA, Guseva OI.
    Klin Med (Mosk); 2003; 81(7):51-5. PubMed ID: 12934313
    [Abstract] [Full Text] [Related]

  • 23. Pulmonary effects of nebivolol.
    Dal Negro R.
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):329-34. PubMed ID: 19638367
    [Abstract] [Full Text] [Related]

  • 24. In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats.
    Toblli JE, Cao G, Casas G, Mazza ON.
    Am J Hypertens; 2006 Dec; 19(12):1226-32. PubMed ID: 17161767
    [Abstract] [Full Text] [Related]

  • 25. Nebivolol: a review of its use in the management of hypertension and chronic heart failure.
    Moen MD, Wagstaff AJ.
    Drugs; 2006 Dec; 66(10):1389-409; discussion 1410. PubMed ID: 16903772
    [Abstract] [Full Text] [Related]

  • 26. The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension.
    Lefebvre J, Poirier L, Poirier P, Turgeon J, Lacourciere Y.
    Br J Clin Pharmacol; 2007 May; 63(5):575-82. PubMed ID: 17094780
    [Abstract] [Full Text] [Related]

  • 27. Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release.
    Kamp O, Metra M, Bugatti S, Bettari L, Dei Cas A, Petrini N, Dei Cas L.
    Drugs; 2010 May; 70(1):41-56. PubMed ID: 20030424
    [Abstract] [Full Text] [Related]

  • 28. Evolving mechanisms of action of beta blockers: focus on nebivolol.
    Mason RP, Giles TD, Sowers JR.
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):123-8. PubMed ID: 19528811
    [Abstract] [Full Text] [Related]

  • 29. Haemodynamic effects and pharmacokinetics of oral d- and l-nebivolol in hypertensive patients.
    Himmelmann A, Hedner T, Snoeck E, Lundgren B, Hedner J.
    Eur J Clin Pharmacol; 1996 Aug; 51(3-4):259-64. PubMed ID: 9010695
    [Abstract] [Full Text] [Related]

  • 30. Nebivolol withdrawal results in blood pressure returning toward pretreatment levels, but without rebound symptoms: phase IV randomized trial.
    Lewin A, Lasseter KC, Dong F, Whalen JC.
    J Am Soc Hypertens; 2012 Aug; 6(3):228-36. PubMed ID: 22421631
    [Abstract] [Full Text] [Related]

  • 31. Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients.
    Doumas M, Tsakiris A, Douma S, Grigorakis A, Papadopoulos A, Hounta A, Tsiodras S, Dimitriou D, Giamarellou H.
    Asian J Androl; 2006 Mar; 8(2):177-82. PubMed ID: 16491268
    [Abstract] [Full Text] [Related]

  • 32. Effect of nebivolol vs. hydrochlorothiazide on the walking capacity in hypertensive patients with intermittent claudication.
    Diehm C, Pittrow D, Lawall H.
    J Hypertens; 2011 Jul; 29(7):1448-56. PubMed ID: 21602713
    [Abstract] [Full Text] [Related]

  • 33. [Nebivolol, a beta blocker of the 3rd generation: modern therapy of arterial hypertension. Results of a multicenter observation study].
    von Fallois J, Faulhaber HD.
    Praxis (Bern 1994); 2001 Mar 15; 90(11):435-41. PubMed ID: 11293936
    [Abstract] [Full Text] [Related]

  • 34. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ, Cohen-Solal A, Böhm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD, SENIORS Investigators.
    J Am Coll Cardiol; 2009 Jun 09; 53(23):2150-8. PubMed ID: 19497441
    [Abstract] [Full Text] [Related]

  • 35. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
    Brixius K, Middeke M, Lichtenthal A, Jahn E, Schwinger RH.
    Clin Exp Pharmacol Physiol; 2007 Apr 09; 34(4):327-31. PubMed ID: 17324145
    [Abstract] [Full Text] [Related]

  • 36. [Use of nebivolol in patients with mild and moderate hypertension].
    Zhigunova LV, Lakhova EL, Iurenev AP.
    Ter Arkh; 2003 Apr 09; 75(3):59-61. PubMed ID: 12718224
    [Abstract] [Full Text] [Related]

  • 37. Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. the QoLaN study.
    Hermans MP, De Coster O, Seidel L, Albert A, Van de Borne P.
    Blood Press Suppl; 2009 Oct 09; 1():5-14. PubMed ID: 20050100
    [Abstract] [Full Text] [Related]

  • 38. EVOLVE (nebivolol evaluation for efficacy and safety in the treatment of hypertension) postmarketing surveillance study.
    Faruqui AA.
    J Indian Med Assoc; 2007 May 09; 105(5):272, 274, 276-7. PubMed ID: 17915798
    [Abstract] [Full Text] [Related]

  • 39. Relationship between the sympatholytic action of nebivolol and hypotension.
    Ward JE, Coles P, Cox H, Eisenhofer G, Angus JA.
    J Cardiovasc Pharmacol; 1992 Jul 09; 20(1):115-24. PubMed ID: 1383620
    [Abstract] [Full Text] [Related]

  • 40. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
    Pronko TP, Zinchuk VV.
    Clin Physiol Funct Imaging; 2009 May 09; 29(3):170-6. PubMed ID: 19170724
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.